The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Single-Molecule Real-Time Sequencing (SMRT) Market Over The 2026–2030 Period?
The single-molecule real-time sequencing (smrt) market has seen substantial growth recently. It is anticipated to expand from $3.36 billion in 2025 to $3.63 billion in 2026, reflecting an 8.1% compound annual growth rate (CAGR). Historically, this market expansion can be linked to the rise of genomic research endeavors, increased adoption of next-generation sequencing platforms, a surging demand for whole genome sequencing, higher investments in life sciences research, and advancements in sequencing chemistry.
The single-molecule real-time sequencing (smrt) market is poised for significant expansion over the coming years. By 2030, its value is projected to reach $4.9 billion, demonstrating a compound annual growth rate (CAGR) of 7.8%. This projected growth is driven by factors such as the expanding application of precision medicine, the escalating need for population-scale genomics, the broadening scope of clinical genomics uses, the increasing incorporation of AI-powered bioinformatics, and greater investment in advanced sequencing technologies. Key developments anticipated during this period encompass the wider embrace of long-read sequencing technologies, the growing application of smrt sequencing for identifying structural variants, the heightened requirement for precise epigenetic analysis, the broadening of real-time sequencing processes, and an intensified focus on resolving complex genomes.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19696&type=smp
Which Factors Are Influencing The Growth Of The Single-Molecule Real-Time Sequencing (SMRT) Market?
The expanding need for precision medicine is anticipated to boost the single-molecule real-time sequencing (SMRT) market in the future. Precision medicine, also known as personalized medicine, represents a medical strategy designed to customize treatment and health management for individual patients, considering their genetic makeup, environmental influences, and lifestyle choices. The growing need for personalized medicine stems from progress in genomic technologies, which facilitates more exact and customized treatments, alongside an increased focus on individual patient care for improved results. Single-molecule real-time sequencing (SMRT) considerably improves precision medicine by delivering comprehensive and precise genomic and epigenetic data, thereby enabling better diagnoses, tailored treatments, and enhanced patient outcomes. For instance, in May 2025, the Personalized Medicine Coalition (PMC), a U.S.-based professional organization, reported that in 2023, the U.S. Food and Drug Administration (FDA) authorized 18 new personalized medicines, accounting for approximately 38% of all newly sanctioned therapeutic molecular entities. Consequently, the increasing demand for precision medicine fuels expansion in the single-molecule real-time sequencing (SMRT) market.
What Segment Categories Shape The Single-Molecule Real-Time Sequencing (SMRT) Market Segment Landscape?
The single-molecule real-time sequencing (smrt) market covered in this report is segmented –
1) By Product: Consumable, Instrument, Services
2) By Application: DNA Sequencing, RNA Sequencing, Epigenetics, Whole Genome Sequencing, Other Applications
3) By End-Users: Hospitals, Diagnostic Laboratories, Biopharmaceutical Companies, Academic Institutes And Research Centers, Other End-Users
Subsegments:
1) By Consumable: Reagents, Sample Preparation Kits, Flow Cells
2) By Instrument: SMRT Sequencers, Accessories, Software
3) By Services: Data Analysis Services, Sequencing Services, Technical Support Services
Who Are The Companies Operating Across The Single-Molecule Real-Time Sequencing (SMRT) Market Value Chain?
Major companies operating in the single-molecule real-time sequencing (smrt) market are Thermo Fisher Scientific Inc., Illumina Inc., Qiagen N.V., BGI Group, 10x Genomics Inc., Ginkgo Bioworks Inc., Oxford Nanopore Technologies Limited, Genewiz Inc., Pacific Biosciences of California Inc., Macrogen Inc., Element Biosciences Inc., Asuragen Inc., BioNano Genomics Inc., Zymo Research Corporation, Dovetail Genomics LLC, SeqWell Inc., Paragon Genomics Inc., Nabsys Inc., Eurofins Scientific SE, Novogene Corporation
Get The Full Single-Molecule Real-Time Sequencing (SMRT) Market Report:
Which Region Leads The Single-Molecule Real-Time Sequencing (SMRT) Market In Overall Market Size?
North America was the largest region in the single-molecule real-time sequencing (SMRT) market in 2025. The regions covered in the single-molecule real-time sequencing (smrt) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Single-Molecule Real-Time Sequencing (SMRT) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Single-Molecule Real-Time Sequencing (SMRT) Market 2026, By The Business Research Company
Molecular Biology Enzymes And Kits And Reagents Market Report 2026
Neuroscience Market Report
https://www.thebusinessresearchcompany.com/report/neuroscience-global-market-report
Typhoid Vi Polysaccharide Vaccine Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model